BETA: Please send your feedback!
Gilead Sciences
GILD:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
About
Biotechnology
Founded 1987
Gilead Sciences, Inc. is a biopharmaceutical company, which discovers, develops and commercializes therapeutics for unmet medical need. It focuses on human immunodeficiency virus and liver diseases, such as chronic hepatitis C virus infection & chronic hepatitis B virus infection, hematology & oncology, and cardiovascular & inflammation as well as respiratory diseases. The company's products include Descovy, Odefsey, Genvoya, Stribild, Complera, Atripla, Truvada, Viread, Emtriva, Tybost, Vitekta, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, Hepsera, Zydelig, Letairis, Ranexa, Lexiscan, Cayston, Tamiflu, AmBisome and Macugen. Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| John F. Milligan, PhD | President, Chief Executive Officer & Director | Male |
| Robin L. Washington, MBA, CPA | Chief Financial Officer & Executive Vice President | Female |
| Gregg H. Alton | Executive VP-Corporate & Medical Affairs | Male |
| John C. Martin, PhD, MBA | Executive Chairman | Male |
| Norbert W. Bischofberger, PhD | Chief Scientific Officer & Executive VP-Research | Male |
| William A. Lee, PhD | Executive Vice President-Research | Male |
| Kevin B. Young | Chief Operating Officer | Male |
| Andrew Cheng, MD, PhD | Executive VP-Clinical Research & Development | Male |
| Brett A. Pletcher | Secretary, Chief Compliance Officer & Executive VP | Male |
| John G. McHutchison, PhD | Executive Vice President-Clinical Research | Male |
| Michael L. Riordan | Founder | Male |
| Katie L. Watson | Executive Vice President-Human Resources | Female |
Mindful Investing Summary
Gilead Sciences - Competitors and Related Companies
How Gilead Sciences stacks up to its peers in the Biotechnology industry or with competing business segments.
Gilead Sciences
GILD:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
Celgene
CELG:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
Eli Lilly
LLY:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
Alexion Pharmaceuticals
ALXN:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—
Vertex Pharmaceuticals
VRTX:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—